Spain gets behind stem cell research
This article was originally published in Scrip
Stem cell research could gain momentum in Spain after the health minister Bernat Soria announced that he was fully committed to this type of research, regardless of the type of cell involved. The speedy transfer of any scientific advances from the lab to clinical practice would also be a priority, he said earlier this month at the 2008 Biobridge congress in Geneva. This was most likely to be achieved within a regulatory framework, he added.
You may also be interested in...
Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.